Wuhan-400 Coronavirus: 1981 Novel Predicts Virus Origin

wuhan-400-coronavirus:-1981-novel-predicts-virus-origin

12-02-20 08:57:00,

Via GreatGameIndia.com,

In a bizarre coincidence, a 1981 fictional novel The Eyes of Darkness by Dean Koontz predicts a Coronavirus like outbreak and its origin. The book talks about how the virus called Wuhan-400, was developed in military labs around the Chinese city of Wuhan from where it got its name. The top secret information of the Biological  weapons Program is later acquired by US intelligence from a Chinese defector. The American military is ultimately successful in creating a vaccine which the Chinese could not.

Wuhan-400 Coronavirus – 1981 Novel predicts Coronavirus like Outbreak and Origin

The Eyes of Darkness is a thriller novel by American writer Dean Koontz, released in 1981. The book focuses on a mother who sets out on a quest to find out if her son truly did die one year ago, or if he is still alive.

Plot

A mother sends her son on a camping trip with a leader who has led this trip into the mountains 16 times before without mishap; that is until this time. Every single camper and leader and driver die with no explanation. As the grieving mother who is the protagonist begins to accept the fact that her son, Danny, is dead she starts getting vicious bully-like attacks from nowhere saying he is not dead, such as writing on chalk boards, words from printers and other various ‘signs’. Along with her new friend, Elliot Stryker, Christina Evans sets out to find out what could have possibly happened on the day that her son ‘died’.

Excerpts on Wuhan-400

The Eyes of Darkness by Dean Koontz, a 1981 novel predicts Coronavirus like outbreak called Wuhan-400 Coronavirus

To understand that you have to go back twenty months. It was around then that a Chinese scientist named Li Chen defected to the United States, carrying a diskette record of China’s most important and dangerous new biological weapon in a decade. They call the stuff “Wuhan-400” because it was developed at their RDNA labs outside of the city of Wuhan, and it was the four-hundredth viable strain of man-made microorganisms created at that research center.

 » Lees verder

Wuhan Institute Of Virology And Chinese Army Submit Patent For Gilead Anti-Ebola Drug To Fight Coronavirus

wuhan-institute-of-virology-and-chinese-army-submit-patent-for-gilead-anti-ebola-drug-to-fight-coronavirus

06-02-20 10:50:00,

Amid growing speculation that nCoV-2019, aka novel coronavirus, aka the virus behind the Wuhan Coronavirus epidemic, was developed in a lab (and not just any lab, but the BSL-4 rated “biological weapons” grade Wuhan Institute of Virology, located in… well, Wuhan) which was then released accidentally (or not) among the broader population – a thesis which China’s official press is scrambling to refute even as more supportive evidence emerges by the day – we would like to point out that earlier this week, the Wuhan Institute of Virology, which as Nature in 2017 said studies the “world’s most dangerous pathogens”, has jointly with the Military Medicine Institute of the People’s Liberation Army Academy of Military Science, i.e. with China’s Army, applied to patent the use of Gilead Sciences’ remdesivir to treat the current coronavirus outbreak.

The company has partnered with Chinese health authorities to run a Phase III clinical trial to assess remdesivir for treatment of the virus. The drug was originally developed to treat the Ebola virus, but wasn’t effective. According to preclinical assays the drug might be effective against the coronavirus, 2019-nCoV, as was published in the New England Journal of Medicine (NEJM). The drug was given to a U.S. patient for compassionate use on day seven of the disease and their condition improved on day eight.

The new clinical trial of an anti-Ebola drug to fight Coronavirus, will be conducted at Friendship Hospital in Beijing, China. The trial will enroll 270 patients with mild and moderate pneumonia caused by the virus.

“Gilead is working closely with global health authorities to respond to the novel coronavirus (2019-nCoV) outbreak through the appropriate experimental use of our investigational compound remdesivir. While there are no antiviral data for remdesivir that show activity against 2019-nCoV at this time, available data in other coronaviruses give us hope,” the company stated.

The Wuhan Institute submitted the patent application jointly with the Military Medicine Institute of the People’s Liberation Army Academy of Military Science. Researchers with both organizations noted in a paper published in Nature’s Cell Research this week that both remdesivir and chloroquine,

 » Lees verder

The Real Umbrella Corp: Wuhan Ultra Biohazard Lab Was Studying “The World’s Most Dangerous Pathogens”

the-real-umbrella-corp:-wuhan-ultra-biohazard-lab-was-studying-“the-world’s-most-dangerous-pathogens”

23-01-20 07:54:00,

Now that not one but seven Chinese cities – including Wuhan, ground zero of the coronavirus epidemic – and collectively housing some 23 million people, are under quarantine…

… comparisons to the infamous Raccoon City from Resident Evil are coming in hot and heavy. And, since reality often tends to imitate if not art then certainly Hollywood, earlier today we jokingly asked if the Medical Research Institute at Wuhan University would end up being China’s version of Umbrella Corp.

Is the Medical Research Institute at Wuhan University, Center for Immunology and Metabolism also called “Umbrella Corp” for short?

https://t.co/CnWxs1uVKT

— zerohedge (@zerohedge) January 23, 2020

As it turns out, it wasn’t a joke, because moments ago it was brought to our attention that in February 2017, Nature penned an extensive profile of what it called the “Chinese lab poised to study world’s most dangerous pathogens.” The location of this BSL-4 rated lab? Why, Wuhan.

A quick read of what this lab was meant to do, prompts the immediate question whether the coronavirus epidemic isn’t a weaponized virus that just happened to escape the lab:

The Wuhan lab cost 300 million yuan (US$44 million), and to allay safety concerns it was built far above the flood plain and with the capacity to withstand a magnitude-7 earthquake, although the area has no history of strong earthquakes. It will focus on the control of emerging diseases, store purified viruses and act as a World Health Organization ‘reference laboratory’ linked to similar labs around the world. “It will be a key node in the global biosafety-lab network,” says lab director Yuan Zhiming.

The Chinese Academy of Sciences approved the construction of a BSL-4 laboratory in 2003, and the epidemic of SARS (severe acute respiratory syndrome) around the same time lent the project momentum. The lab was designed and constructed with French assistance as part of a 2004 cooperative agreement on the prevention and control of emerging infectious diseases. But the complexity of the project, China’s lack of experience, difficulty in maintaining funding and long government approval procedures meant that construction wasn’t finished until the end of 2014.

 » Lees verder